.
23/06/2021
Understanding how a small molecule compound interacts with its target protein is essential for developing successful drugs. In vitro measurements of ligand affinity and duration of drug-target interactions (e.g., residence time) often do not translate in vivo. Using the NanoBRET™ Target Engagement (TE) method, we will show the impact of oncogenic KRAS (G12C) on engagement potency for downstream effectors, including BRAF. We have also developed a pan-KRAS NanoBRET™ TE assay and will demonstrate detection of a variety of orthosteric and allosteric engagement mechanisms at this challenging target.
You will learn about:
•NanoBRET TE assays broadly enable the quantitative determination of compound affinity/potency for specific targets inside
•Protein-protein interactions and target protein activation stats have a strong influence on drug compound pharmacology using the RAS-MAPK as an example
•NanoBRET TE assays can be used to connect structural features of inhibitors to their biochemical properties in a cellular system
Registration link : https://bit.ly/3hLF7bb Free Registration
Media mikrobiologi adalah tulang punggung setiap laboratorium yang terlibat dalam studi atau aplikasi mikroorganisme. Fungsi…
Indolab Utama menghadirkan penawaran spesial akhir tahun!Dapatkan diskon hingga 50% untuk berbagai produk laboratorium pilihan.…
Seiring meningkatnya volume sampel, terutama dalam studi genetik skala besar (genomik) dan uji diagnostik klinis…
Indolab Utama baru saja menyelesaikan training seru Isolasi DNA menggunakan kit A1120 di UMMADA Cirebon!…
Kami bangga menjalin kolaborasi dengan RSUD Koja dalam meningkatkan layanan patologi mereka. Indolab Utama telah…
Fenomena bioluminescence, yaitu produksi cahaya oleh organisme hidup melalui reaksi kimia, telah lama memukau manusia…